New Zealand markets closed

Hoth Therapeutics, Inc. (HOTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3000+0.0300 (+2.36%)
At close: 03:59PM EST
1.2900 -0.01 (-0.77%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 5.65M
Enterprise value -6.20M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.53
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.66

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 3-55.12%
S&P500 52-week change 327.55%
52-week high 34.3000
52-week low 30.9900
50-day moving average 31.3386
200-day moving average 31.8188

Share statistics

Avg vol (3-month) 3266.51k
Avg vol (10-day) 350.65k
Shares outstanding 54.35M
Implied shares outstanding 64.35M
Float 84.08M
% held by insiders 10.93%
% held by institutions 11.82%
Shares short (15 Feb 2024) 484.75k
Short ratio (15 Feb 2024) 40.79
Short % of float (15 Feb 2024) 41.97%
Short % of shares outstanding (15 Feb 2024) 41.95%
Shares short (prior month 12 Jan 2024) 4133.75k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 326 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-53.54%
Return on equity (ttm)-100.65%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-9.62M
Diluted EPS (ttm)-4.7100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.85M
Total cash per share (mrq)2.73
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)7.63
Book value per share (mrq)2.42

Cash flow statement

Operating cash flow (ttm)-7.93M
Levered free cash flow (ttm)-5.07M